Low dose desensitisation does not reduce the toxicity of sulphasalazine in rheumatoid arthritis.

OBJECTIVE: To examine the proposal that pretreatment low dose desensitisation may reduce the incidence of toxicity of sulphasalazine in the treatment of rheumatoid arthritis (RA). METHODS: A double blind, placebo controlled trial was performed with 422 patients satisfying the American College of Rhe...

Descripción completa

Detalles Bibliográficos

Publicado en:	Ann Rheum Dis
Autores principales:	McInnes, I B, Porter, D, Murphy, E A, Thomson, E A, Madhok, R, Hunter, J A, Pullar, T, Capell, H A
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	BMJ Publishing Group 1996
Materias:	Research Article
Acceso en línea:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC1010172/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8660109/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/ard.55.5.328
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!